Dara Biosciences (DARA +20.7%) regains yesterday's upward move plus more after saying it's...


Dara Biosciences (DARA +20.7%) regains yesterday's upward move plus more after saying it's signed an exclusive agreement with The Helsinn Group of Switzerland for the U.S. commercial rights to Gelclair. Gelclair is an FDA-cleared topical gel topical gel used to reduce pain from oral mucositis.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs